- Home
- PMCB vs CUTR Comparison
PMCB vs CUTR Comparison
Compare PMCB & CUTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- CUTR
- Stock Information
- Founded
- PMCB 1996
- CUTR 1988
- Country
- PMCB United States
- CUTR United States
- Employees
- PMCB N/A
- CUTR N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- CUTR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PMCB Health Care
- CUTR Health Care
- Exchange
- PMCB Nasdaq
- CUTR Nasdaq
- Market Cap
- PMCB 11.4M
- CUTR 9.2M
- IPO Year
- PMCB N/A
- CUTR 2004
- Fundamental
- Price
- PMCB $1.76
- CUTR $0.43
- Analyst Decision
- PMCB
- CUTR Hold
- Analyst Count
- PMCB 0
- CUTR 3
- Target Price
- PMCB N/A
- CUTR $3.00
- AVG Volume (30 Days)
- PMCB 27.2K
- CUTR 174.3K
- Earning Date
- PMCB 03-17-2025
- CUTR 03-20-2025
- Dividend Yield
- PMCB N/A
- CUTR N/A
- EPS Growth
- PMCB N/A
- CUTR N/A
- EPS
- PMCB 0.74
- CUTR N/A
- Revenue
- PMCB N/A
- CUTR $155,210,000.00
- Revenue This Year
- PMCB N/A
- CUTR N/A
- Revenue Next Year
- PMCB N/A
- CUTR $4.61
- P/E Ratio
- PMCB $2.37
- CUTR N/A
- Revenue Growth
- PMCB N/A
- CUTR N/A
- 52 Week Low
- PMCB $1.39
- CUTR $0.28
- 52 Week High
- PMCB $2.58
- CUTR $3.00
- Technical
- Relative Strength Index (RSI)
- PMCB 60.08
- CUTR 48.15
- Support Level
- PMCB $1.57
- CUTR $0.37
- Resistance Level
- PMCB $1.66
- CUTR $0.46
- Average True Range (ATR)
- PMCB 0.12
- CUTR 0.06
- MACD
- PMCB 0.02
- CUTR 0.00
- Stochastic Oscillator
- PMCB 68.89
- CUTR 37.50
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About CUTR Cutera Inc.
Cutera Inc is a medical device company that specializes in designing, developing, manufacturing, marketing, and servicing laser and other energy-based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States segment. Its products enable medical practitioners to perform safe procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions.